Hansoh Pharmaceutical Group Company Limited (FRA:3KY)
Germany flag Germany · Delayed Price · Currency is EUR
4.080
+0.020 (0.49%)
At close: Jan 30, 2026

FRA:3KY Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
27,10422,62222,43517,61514,7024,285
Short-Term Investments
-780.441,9371,4711,8829,241
Trading Asset Securities
17.5517.24512.412,5442,357200
Cash & Short-Term Investments
27,12123,41924,88421,63118,94113,726
Cash Growth
15.42%-5.88%15.04%14.20%38.00%-5.98%
Accounts Receivable
2,7943,1703,2143,5783,6763,127
Other Receivables
-94.2780.8947.4252.7482.82
Receivables
2,7943,2643,2953,6263,7293,210
Inventory
653.49651.22575.78447.89410.13298.73
Prepaid Expenses
-0.883.831.730.972.11
Other Current Assets
250.62106.41124.83125.698.0548.61
Total Current Assets
30,81927,44228,88325,83223,17917,286
Property, Plant & Equipment
3,2033,2473,2803,4503,4752,304
Long-Term Investments
732.63702.28684.71653.65394.9728.39
Other Intangible Assets
289.41245.29177.4233.4217.049.89
Other Long-Term Assets
27.2621.3213.9333.2993.41,164
Total Assets
35,07131,65833,03930,00227,16020,792
Accounts Payable
268.65217.85163.76222.3248.33124.38
Accrued Expenses
1,7482,0901,9691,9252,2011,877
Current Portion of Long-Term Debt
40.9840.874,183---
Current Portion of Leases
17.1316.0116.0915.549.9711.04
Current Income Taxes Payable
138.7746.6785.6590.94134.211.4
Current Unearned Revenue
186.2119.2338.4725.122.2195.69
Other Current Liabilities
1,201264.84406.37340.93408.47469.92
Total Current Liabilities
3,6012,6956,8632,6203,0242,690
Long-Term Debt
--39.744,2833,743-
Long-Term Leases
58.7561.0164.7179.5774.9281.71
Long-Term Deferred Tax Liabilities
293.79200.19255.02350.66266.75121.81
Other Long-Term Liabilities
21.2821.5221.9922.4622.9323.4
Total Liabilities
3,9752,9787,2447,3557,1312,916
Common Stock
0.050.050.050.050.050.05
Additional Paid-In Capital
14,32214,00014,09613,93214,02414,009
Retained Earnings
16,31813,91811,4058,7806,9104,578
Treasury Stock
-3.28-13.22-108.63-28.03-57.97-
Comprehensive Income & Other
459.47775.05402.88-36.91-846.92-710.99
Shareholders' Equity
31,09728,68025,79522,64720,02917,876
Total Liabilities & Equity
35,07131,65833,03930,00227,16020,792
Total Debt
116.86117.894,3044,3783,82892.75
Net Cash (Debt)
27,00423,30120,58017,25315,11413,634
Net Cash Growth
15.51%13.22%19.29%14.15%10.86%-6.55%
Net Cash Per Share
4.533.923.422.912.522.32
Filing Date Shares Outstanding
5,9465,9345,9245,9205,9185,919
Total Common Shares Outstanding
5,9465,9345,9245,9205,9185,919
Working Capital
27,21824,74722,02023,21220,15614,596
Book Value Per Share
5.234.834.353.833.383.02
Tangible Book Value
30,80728,43525,61722,61420,01217,866
Tangible Book Value Per Share
5.184.794.323.823.383.02
Buildings
-2,4812,3242,3112,2791,325
Machinery
-2,3632,2682,1301,7931,484
Construction In Progress
-162.99367.12358.52501.69347.73
Leasehold Improvements
-48.148.141.2510.99.93
Source: S&P Global Market Intelligence. Standard template. Financial Sources.